Alemtuzumab in clinical practice: a British Columbia experience.
Hui D, Lam W, Toze C, Delorme M, Noble M, Klimo P, Sutherland J, Gill K, Connors J, Sehn L.
Hui D, et al. Among authors: sutherland j.
Leuk Lymphoma. 2008 Feb;49(2):218-26. doi: 10.1080/10428190701760029.
Leuk Lymphoma. 2008.
PMID: 18231907